Addison Whitney

Addison Whitney, powered by Syneos Health, is a global branding firm that partners with companies to create influential, enduring brands.

[Addison Whitney @AddisonWhitney]

🚨 Hot off the press: Important dates are now released for the 76th INN Consultation!

As a bonus, don’t miss out on the new BioBook that has been updated after three years --> https://t.co/C0hiGnQLlZ

[Addison Whitney @AddisonWhitney]

Have you seen the 2023 Color of the Year? 🎨 "Viva Magenta" was selected for its welcoming yet rebellious spirit rooted in nature. https://t.co/Fv23nch5K1

[Addison Whitney @AddisonWhitney]

💡 Our parent company, @SyneosHealth, shares insight on the technology poised to change how we all see data. Learn more in the annual report - 2023 Health Trends: Personally, Purposely Building What's Next. ⤵️ https://t.co/EkuCi433yg

[Addison Whitney @AddisonWhitney]

Happy December! As we wrap up 2022, this month’s playlist, filled with classic throwbacks and punchy alt-rock tracks, will leave you feeling inspired to embrace the infinite possibilities of your new year. 🎉https://t.co/dAfh2z0mbQ

[Addison Whitney @AddisonWhitney]

Planning to tune-up your brand in 2023? 🛠 Consider evaluating its digital accessibility. Here we detail the importance of ADA-compliant websites: https://t.co/Ll7FOBZUaf

[Addison Whitney @AddisonWhitney]

How your brand translates in brick-and-mortar matters. 🧱 Learn more about the art of branded environments: https://t.co/6w486UcFcm

[Addison Whitney @AddisonWhitney]

How much is too much when it comes to stand-out visual identities? Read our thoughts on successful and strategic creative: https://t.co/QNt8aYFy7P

[Addison Whitney @AddisonWhitney]

Investing in good creative will always be on trend. 🎨
https://t.co/dXWnIL2Mkd

[Addison Whitney @AddisonWhitney]

Want to bolster your company's therapeutic impact? 📈 See how a larger brand strategy linking names can do just that --> https://t.co/Cb13k2OQGM

[World Health Organization (WHO) @WHO]

It is Medication Safety Week.

Medicines 💊 can cause side effects. To improve the safety of medicines and to save lives, report it.

Learn more 👉https://t.co/U5alitlrBj #MedSafetyWeek

[Addison Whitney @AddisonWhitney]

It is always #MedSafetyWeek at Addison Whitney! 💊 Learn how our process offers Cleaner, Safer and Smarter results: https://t.co/vNkngOkVkk

[Addison Whitney @AddisonWhitney]

Happy November! 🍂 Filled with revitalizing throwbacks inspired by recent #creative work across multiple different industries, this month’s playlist will carry you through that end-of-year push and into the new year. Happy listening! https://t.co/Rxb3pwEyEj

[Addison Whitney @AddisonWhitney]

What does it mean to invest in a pharmaceutical #naming agency? Here we explain the benefits of working with an experienced partner: https://t.co/IJ7pOor5Eb

[Addison Whitney @AddisonWhitney]

Brand standards can effectively protect the future of your brand 💰 Download our guide to learn more about best practices: https://t.co/crXtQyFahA

[Addison Whitney @AddisonWhitney]

What a way to start the week! 🎉 IMJUDO® in combination with IMFINZI® is now FDA approved for treatment of liver cancer. Congratulations to AstraZeneca!

[Addison Whitney @AddisonWhitney]

Ever wonder how long-established brands are able to maintain relevancy? We have some thoughts ✍🏽 #brandinginsight https://t.co/mXshT1fEDi

[Addison Whitney @AddisonWhitney]

AI has the potential to shape #branding from visual elements to trademarks. 🤖 Is your brand prepared? https://t.co/WJwrm98sAt

[Addison Whitney @AddisonWhitney]

The path to trademark clearance is complex. 🗺 Download an insightful conversation with our VP of Trademarks here: https://t.co/omWKcw8FjM

[Addison Whitney @AddisonWhitney]

What a great PTMG Conference! 💡 We are proud to have been represented by trademark expert Jennifer Sirop, who brought back invaluable insights. Have trademark questions of your own? Connect with us: https://t.co/lyGUdaC5bX. #pharmaceuticalindustry #trademarks

[Addison Whitney @AddisonWhitney]

We share in the excitement of @TevaUSA's latest FDA approval, Alvaiz!